The World Health Organization says there’s no evidence that contracting the coronavirus makes you immune to a second infection.
This development throws a wrench in long-term coronavirus management plans like “immunity passports,” which would allow people who have recovered from the disease to resume normal activities on a faster timetable.
For top medical experts, increased testing is still the most promising strategy to get people and economies back up and rolling. In the US, Dr. Anthony Fauci says the country is testing about 1.5 million to 2 million people a week, and should double its efforts over the next several weeks.
Meanwhile, New York hospitals are studying famotidine, a common heartburn drug, to see if it could be effective against Covid-19. Preliminary results from a clinical trial of remdesivir, that much-discussed experimental antiviral drug, could be released in the next two weeks.
Steven Umidha is a data and financial journalist with over 14 years of work experience in journalism and communication.
He specialises in finance and economics reporting as well as on the causes, impacts, and solutions of global warming, conservation, pollution and sustainability, often blending scientific literacy with journalist ethics, while involving policy analysis and multimedia storytelling across various platforms in highlighting issues from biodiversity loss to ecological justice.
Besides being the Founder of Financial Fortune Media, Umidha has previously worked with the Standard Media Group, Mediamax Networks LTD, bird story agency, Business Journal Africa, and Financial Post among other outlets.
He can be reached on: Email: info@financialfortunemedia.com
Cell: +(254)726-879-488